| A review on the medicinally important plants of the family Cucurbitaceae. K Dhiman, A Gupta, DK Sharma, NS Gill, A Goyal | 210 | 2012 |
| Cerebrospinal fluid biomarkers for understanding multiple aspects of Alzheimer’s disease pathogenesis K Dhiman, K Blennow, H Zetterberg, RN Martins, VB Gupta Cellular and molecular life sciences 76, 1833-1863, 2019 | 99 | 2019 |
| Cerebrospinal fluid neurofilament light concentration predicts brain atrophy and cognition in Alzheimer's disease K Dhiman, VB Gupta, VL Villemagne, D Eratne, PL Graham, C Fowler, ... Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring 12 (1 …, 2020 | 84 | 2020 |
| Evaluation of antioxidant and antiulcer activity of traditionally consumed Cucumis melo seeds. NS Gill, J Bajwa, P Sharma, K Dhiman, S Sood, PD Sharma, B Singh, ... | 55 | 2011 |
| Evaluation of therapeutic potential of traditionally consumed Cucumis melo seeds NS Gill, J Bajwa, K Dhiman, P Sharma, S Sood, PD Sharma, B Singh, ... Deakin University, 2011 | 52 | 2011 |
| Evaluation of free radical scavenging, anti-inflammatory and analgesic potential of Benincasa hispida seed extract. NS Gill, K Dhiman, J Bajwa, P Sharma, S Sood | 51 | 2010 |
| A pilot study of the utility of cerebrospinal fluid neurofilament light chain in differentiating neurodegenerative from psychiatric disorders: A ‘C-reactive protein’for … D Eratne, SM Loi, N Walia, S Farrand, QX Li, S Varghese, M Walterfang, ... Australian & New Zealand Journal of Psychiatry 54 (1), 57-67, 2020 | 49 | 2020 |
| Free radical scavenging potential and total phenolic and flavonoid content of Ziziphus mauritiana and Ziziphus nummularia fruit extracts AG Dureja, K Dhiman International Journal of Green Pharmacy (IJGP) 6 (3), 2012 | 48 | 2012 |
| Comparative analysis of aducanumab, zagotenemab and pioglitazone as targeted treatment strategies for Alzheimer’s disease M Abyadeh, V Gupta, V Gupta, N Chitranshi, Y Wu, A Amirkhani, ... Aging and disease 12 (8), 1964, 2021 | 46 | 2021 |
| Cerebrospinal fluid neurofilament light chain differentiates primary psychiatric disorders from rapidly progressive, Alzheimer's disease and frontotemporal disorders in … D Eratne, SM Loi, QX Li, C Stehmann, CB Malpas, A Santillo, S Janelidze, ... Alzheimer's & Dementia 18 (11), 2218-2233, 2022 | 26 | 2022 |
| Evaluation of free radical scavenging and antiulcer potential of methanolic extract of Benincasa hispida seeds NS Gill, K Dhiman, P Sharma, J Bajwa, S Sood, PD Sharma, B Singh, ... Deakin University, 2011 | 20 | 2011 |
| Neuroserpin, a crucial regulator for axogenesis, synaptic modelling and cell–cell interactions in the pathophysiology of neurological disease A Godinez, R Rajput, N Chitranshi, V Gupta, D Basavarajappa, S Sharma, ... Cellular and Molecular Life Sciences 79 (3), 172, 2022 | 12 | 2022 |
| Study on Cucumis melo var. utilissimus seeds for the therapeutic potential NS Gill, P Sharma, J Bajwa, K Dhiman, S Sood, PD Sharma, M Bali Deakin University, 2010 | 11 | 2010 |
| A comprehensive insight into the development of animal models for obesity research A Goyal, AG Dureja, DK Sharmaρ, K Dhiman Global J. Med. Res. 12, 39-44, 2012 | 8 | 2012 |
| Cerebrospinal fluid neurofilament light concentration predicts brain atrophy and cognition in Alzheimer’s disease. Alzheimers Dement Diagn Assess Dis Monit 2020; 12: e12005 K Dhiman, VB Gupta, VL Villemagne, D Eratne, PL Graham, C Fowler, ... | 8 | |
| Decreased cerebrospinal fluid neuronal pentraxin receptor is associated with PET-Aβ load and cerebrospinal fluid Aβ in a pilot study of Alzheimer’s disease B Lim, C Fowler, QX Li, C Rowe, K Dhiman, VB Gupta, CL Masters, ... Neuroscience letters 731, 135078, 2020 | 7 | 2020 |
| Cerebrospinal fluid levels of fatty acid–binding protein 3 are associated with likelihood of amyloidopathy in cognitively healthy individuals K Dhiman, VL Villemagne, C Fowler, P Bourgeat, QX Li, S Collins, ... Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring 14 (1 …, 2022 | 3 | 2022 |
| Elevated levels of synaptic protein GAP‐43 associate with brain tauopathy, atrophy and cognition in Alzheimer’s disease: Biomarkers (non‐neuroimaging)/Differential diagnosis K Dhiman, VLL Villemagne, D Eratne, PL Graham, CJ Fowler, P Bourgeat, ... Alzheimer's & Dementia 16, e044098, 2020 | 3 | 2020 |
| Cerebrospinal fluid neurofilament light predicts risk of dementia onset in cognitively healthy individuals and rate of cognitive decline in mild cognitive impairment: a … K Dhiman, VL Villemagne, C Fowler, P Bourgeat, QX Li, S Collins, ... Biomedicines 10 (5), 1045, 2022 | 2 | 2022 |
| Neurofilament light chain in psychiatric and neurodegenerative disorders: A ‘c‐reactive protein’for the brain? Biomarkers (non‐neuroimaging)/plasma/serum/urine biomarkers D Eratne, SM Loi, A Santillo, QX Li, C Chadunow, C Stehmann, ... Alzheimer's & Dementia 16, e041347, 2020 | 1 | 2020 |
